|
|
Volumn 3, Issue SUPPL. 2, 2001, Pages 35-39
|
|
Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation
|
|
Author keywords
CytoGam ; Ganciclovir; Hyperimmune globulin; Intestinal; Liver
|
|
Indexed keywords
ALEMTUZUMAB;
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
GRAFT REJECTION;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFECTION CONTROL;
INFECTION RISK;
INTESTINE TRANSPLANTATION;
LIVER TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
VIRUS LOAD;
ADULT;
ANTIVIRAL AGENTS;
CHILD;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
GANCICLOVIR;
HUMANS;
IMMUNOGLOBULINS;
INTESTINES;
LIVER TRANSPLANTATION;
ORGAN TRANSPLANTATION;
RISK FACTORS;
SURVIVAL ANALYSIS;
|
|
EID: 0035691003
PISSN: 13982273
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-3062.2001.00007.x Document Type: Article |
|
Times cited : (23)
|
|
References (2)
|
